<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04411017</url>
  </required_header>
  <id_info>
    <org_study_id>EII_Prep</org_study_id>
    <nct_id>NCT04411017</nct_id>
  </id_info>
  <brief_title>Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease</brief_title>
  <acronym>EII_Prep</acronym>
  <official_title>Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial evaluating efficacy of bowel cleansing solutions in patients with Inflammatory&#xD;
      Bowel Disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Simple blind, randomized study evaluating efficacy of 1LPEG vs 2L PEG vs 2L sodium&#xD;
      picosulfate in bowel cleansing of patients diagnosed of Inflammatory Bowel Disease undergoing&#xD;
      diagnostic or follow-up routine colonoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">July 20, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bowel cleansing</measure>
    <time_frame>1 year</time_frame>
    <description>Boston Bowel Preparation Score (BBPS), a 10-point scale assessing bowel preparation after all cleansing maneuvers are completed by the endoscopist. Each region of the colon receives a &quot;segment score&quot; from 0 to 3 and these segment scores are summed for a total BBPS score ranging from 0 to 9. Therefore, the maximum BBPS score for a perfectly clean colon without any residual liquid is 9 and the minimum BBPS score for an unprepared colon is 0.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment related adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>Number of Participants with symptomatology related to intervention in each arm of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preparation Tolerability: total volume of solution finally taken by the patient</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluation of total volume of solution finally taken by the patient</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>1L PEG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2L PEG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2L sodium picosulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopy</intervention_name>
    <description>Colonoscopy</description>
    <arm_group_label>1L PEG</arm_group_label>
    <arm_group_label>2L PEG</arm_group_label>
    <arm_group_label>2L sodium picosulfate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between 18y and 90y&#xD;
&#xD;
          -  Patients with a diagnosis of IBD undergoing follow-up or screening colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients &lt;18y or &gt;90y&#xD;
&#xD;
          -  Pregnant Women&#xD;
&#xD;
          -  Patients with a past history of inadequate bowel cleansing in a colonoscopy performed&#xD;
             in the previous 12 months prior to initiation of study&#xD;
&#xD;
          -  Patients with a history of bowel resection&#xD;
&#xD;
          -  Patients undergoing therapeutic colonoscopy&#xD;
&#xD;
          -  Patients unable to understand study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Dolores Martin Arranz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz. IdiPaz. Universidad Autónoma de Madrid.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <state>Madrd</state>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2020</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>María Dolores Martín Arranz, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Inflammatory Bowel Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

